Drug discovery and formulation development for acute pancreatitis

• Main Authors: Xue Jiang, Ya-Wen Zheng, Shihui Bao, Hailin Zhang, Ruijie Chen, Qing Yao, Longfa Kou
• Format: Article
• Language: English
• Published: Taylor & Francis Group 2020-01-01
• Series: Drug Delivery
• Subjects: acute pancreatitis; inflammation; traditional chinese medicine; drug delivery; nanoparticles
• Online Access: http://dx.doi.org/10.1080/10717544.2020.1840665

Acute pancreatitis is a sudden inflammation and only last for a short time, but might lead to a life-threatening emergency. Traditional drug therapy is an essential supportive method for acute pancreatitis treatment, yet, failed to achieve satisfactory therapeutic outcomes. To date, it is still challenging to develop therapeutic medicine to redress the intricate microenvironment promptly in the inflamed pancreas, and more importantly, avoid multi-organ failure. The understanding of the acute pancreatitis, including the causes, mechanism, and severity judgment, could help the scientists bring up more effective intervention and treatment strategies. New formulation approaches have been investigated to precisely deliver therapeutics to inflammatory lesions in the pancreas, and some even could directly attenuate the pancreatic damages. In this review, we will briefly introduce the involved pathogenesis and underlying mechanisms of acute pancreatitis, as well as the traditional Chinese medicine and the new drug option. Most of all, we will summarize the drug delivery strategies to reduce inflammation and potentially prevent the further development of pancreatitis, with an emphasis on the bifunctional nanoparticles that act as both drug delivery carriers and therapeutics.